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5.1  Abstract
Our aim was to determine whether a fermented milk drink containing probiotics could improve the bowel 
habits of frail elderly individuals living in a nursing home. A total of 135 participants were enrolled in this 
pilot study. The bowel habits (stool quality and bowel movements) were recorded by nursing staff during a 
baseline period of 3 weeks. After this period participants received daily a fermented milk drink containing 
minimally 6.5×109 colony forming units of Lactobacillus casei Shirota (LcS) for 6 weeks. During this period, 
bowel habits were recorded and compared to baseline period. Forty-four participants (74-99 years old) were 
compliant and used for analysis. Consumption of fermented milk containing LcS significantly increased 
the percentage of ideal stool types per week (P<0.01), lowered the percentage of constipation stool types 
per week (P<0.01) and significantly lowered the percentage of diarrhoea stool types per week (P=0.016) 
as compared to the baseline period. The study product had no significant effect on bowel movements. 
During the study, no changes in laxative usage or adverse events associated with the study product were 
reported. Our results suggest that a fermented milk containing LcS significantly improves the bowel habits 





The general population is rapidly ageing due to socioeconomic and medicinal advances. It is estimated that 
in the near future, the population of children under 5 years will be outnumbered by elderly over 65 years old 
(Duncan and Flint, 2013). This global issue puts an overwhelming burden on healthcare systems in order 
to maintain a good quality of life (QoL) for elderly individuals (Duncan and Flint, 2013). Elderly (≥65 y) 
often suffer from more than one chronic condition, and approximately 87% of elderly individuals living at 
home receive at least one prescription drug (Barat et al., 2000).
It is well understood that ageing is associated with a change in the microbiota (Biagi et al., 2012). Ageing 
may cause a change in the Firmicutes to Bacteroidetes ratio (Mariat et al., 2009). Also, there seems to be a 
decline in the heterogeneity of microbial species with, for example, bifidobacteria becoming less abundant 
(Biagi et al., 2012). Moreover, the microbiota of individuals in long stay residential care appeared to be 
less diverse when compared to communitydwelling elderly (Claesson et al., 2012). A clear consensus on 
the changes of the microbiota upon ageing remains however to be established (Magrone and Jirillo, 2013), 
and also seems to be complicated by differences caused by geographical origin (Mueller et al., 2006). A 
disbalance in the microbiota is associated with a variety of illnesses (Sekirov et al., 2010). For instance, there 
are indications that constipation may be associated with changes in the intestinal flora (Van Tongeren et al., 
2005). Constipation is a disorder that is especially prevalent amongst the older population (Gandell et al., 
2013). The prevalence in nursing homes seems to be even higher with respect to communitydwelling elderly. 
An American study estimated that the prevalence of constipation may be as high as 74% in nursing homes 
(Rao and Go, 2010). In addition to the altered microbiota, certain disease states such as hypothyroidism, 
hypercalcemia, stroke and Parkinson disease as well as drugs commonly taken by elderly (e.g. antidiarrheal 
agents, calcium-channel blockers, oral iron supplements and opioid analgesics) are known causes for 
constipation (Gandell et al., 2013). Constipation is associated with a wide variety of complications, especially 
in the frail elderly population. It often leads to anorexia, nausea and pain associated with functional decline 
(Gandell et al., 2013). Furthermore, it can lead to a decreased QoL and increased costs for health care 
facilities to manage the problem.
Restoring the disbalanced microbiota to reduce disease risk by using probiotics might improve the overall 
health of elderly living in nursing homes. Probiotics are defined by the Food and Agricultural Organization 
and World Health Organization (FAO/WHO) as ‘live microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host’ (FAO/WHO, 2001); this consensus is recently reinforced by the 
International Scientific Association for Probiotics and Prebiotics (ISAPP; Hill et al., 2014). Several studies 
indeed demonstrate a beneficial potential of probiotics for constipation (Chmielewska and Szajewska, 2010; 
Koebnick et al., 2003). Hence, probiotic intervention amongst the residents may lead to an improvement 
of the QoL, due to a lowering of the constipation prevalence.
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Antibiotic usage, which is relatively high in elderly, disturbs the gastrointestinal (GI) microbiota and may 
increase the incidence of a Clostridium difficile infection (Hell et al., 2013). This highly prevalent pathogen 
in the elderly, with a carriage rate of around 20% in home care residents (Karlström et al., 1998), can cause 
antibiotic-associated diarrhoea (AAD). Meta-analyses indicate that probiotics may be beneficial for the 
treatment of AAD (Hell et al., 2013; Hempel et al., 2012; Videlock and Cremonini, 2012). In addition, 
probiotics for non-AAD, which is also frequently encountered within the elderly population (Van Dessel et 
al., 2005), show promising results (Floch et al., 2011). Iatrogenic bowel irregularities, such as AAD and C. 
difficile-associated diarrhoea can lead to serious complications. Recent studies, however, demonstrate that 
administration of a commercially available probiotic leads to substantial healthcare cost-savings (Claassen, 
2014).
Multiple studies focusing on management of diarrhoea or constipation using probiotics have appeared over 
the last years. However, to the best of our knowledge, no research is available that focuses on improving 
bowel habits (including both diarrhoea and constipation) of residents in nursing homes with a very high age. 
This pilot study therefore investigates the possibility to improve bowel habits using a fermented milk drink 
containing Lactobacillus casei Shirota (LcS) on frail elderly residents of a nursing home in the Netherlands.
5.3.  Methodology
5.3.1. Design and outcome parameters
This food supplement pilot study was conducted in a nursing home in the Netherlands between March 
and May 2013. The study was designed in two phases, a baseline period of 3 weeks (weeks 1-3) and 
an intervention period of 6 weeks (weeks 4-9; total of 63 days; Figure 5.1). During the baseline period 
participants did not receive the study product. During the intervention period, participants received daily 
a fermented milk beverage.
The study product was a commercially available probiotic product, Yakult Original (YOR), containing a 
minimum of 1.0×108 cfu/ml L. casei strain Shirota (YIT9029) per bottle. Participants orally received one 
bottle of 65 ml during breakfast per day (minimally 6.5×109 cfu/day). The study product was provided by 
Yakult Nederland BV (Amstelveen, the Netherlands).
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Figure 5.1. Sequential trial lay-out.
During the complete course of 9 weeks, participants were accompanied to the bathroom by nursing staff 
to document the primary outcome of stool quality and bowel movements. Stool quality was determined 
according to the 7-point Bristol stool scale (developed by K.W. Heaton and S.J. Lewis, Bristol University). 
Bristol stool type 1 and 2 were associated with constipation, type 3 and 4 with ideal stool and type 5, 6 
and 7 with diarrhoea (Figure 5.2). Bowel movements were calculated as the number of stools per time-
unit and related to the Rome III criteria for functional constipation (Drossman et al., 2006). The criterion 
for functional constipation was ≤2 stools per week. In addition to bowel habits, other parameters, such as 
laxative usage and adverse events were monitored.
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Figure 5.2.Bristol Stool scale, developed by K.W. Heaton and S.J. Lewis, Bristol University; adapted by J. Orsouw, © 2014.
5.3.2. Study population and criteria
The study population consisted of ‘high maintenance’ frail elderly individuals, with a limited life-span 
(average ~1.5 year), living in a nursing home. All participants were recruited from the same nursing home 
after informed consent was obtained from first degree relatives. Residents in the nursing home ageing 
≥70 years were considered eligible for inclusion. Participants were excluded from the study if (1) their life 
expectancy was ≤6 months; (2) required intensive medication; or (3) were severely ill (as determined by 
the in-house physician). Subjects were accompanied to the bathroom by nursing staff. This also allowed 
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for consistent and reliable data collection. In addition, during the baseline period of 3 weeks, subjects were 
allowed to consume a maximum of two bottles of YOR. During the intervention period, subjects were 
allowed to miss a maximum of two bottles of YOR. During the complete course of the study, participants 
were not allowed to consume any other probiotic products. There were no major alterations in regular diet 
of the participants during the study as controlled by the institution.
5.3.3. Statistical analysis
The sample size was estimated based on data provided by Koebnick et al. (2003). Taking into account 
poor compliance and the sequential design of the study, a sample size of 135 participants would provide 
sufficient power for this pilot study. All data were tested for normal distribution using a Shapiro-Wilk test 
in combination with Q-Q (Quantile- Quantile) plots for additional verification. Normally distributed data 
were analysed using a paired t-test, whereas not normally distributed data were analysed using a Wilcoxon-
signed rank test (a non-parametric test). Data analysis was performed using R Studio (version 0.98.501) 
statistical software, and IBM SPSS statistics v.20 (IBM, Armonk, NY, USA). A P-value <0.05 was considered 
significant.
5.4.  Results
In total 135 subjects gave consent and were recruited to participate in the study. Table 5.1 describes the 
baseline characteristics of the study population. Due to serious noncompliance (subjects went to the 
bathroom independently), only 44 subjects with all data on bowel habits available were considered eligible 
for analysis. The age range of the perprotocol (PP) population was 74-99 years old (mean 83.8 y).
There was no difference in laxative usage; the average number of laxatives used per patient per week during 
intervention was not significantly different from the baseline period (P=0.091). Seven subjects (15.9%) 
did not receive laxatives during the entire study duration. All laxatives were empirically supplemented, 
with Movicolon as the most frequent prescribed laxative. Other laxatives were lactulose, plum compote, 
bisacodyl, Norgalax and magnesium-oxide (MgO).
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Table 5.1. Demographics and characteristics of the participants.
Enrolled subjects, n 135
Drop-out rate, n (%) 91 (67.4)
Mortality, P1/P2 (%) 4.4 / 2.3
Per protocol Subjects, n 44
Male/Female, n/n 11 / 33








The total number of stools per week per participant during the baseline period was 5.2±1.5 compared 
to 5.4±1.7 stools per week during the intervention period (P=0.236; Figure 5.3A). When comparing 
the percentage of ideal stools (type 3 and 4) during the baseline- and intervention period, 36 (~82%) 
participants experienced an improvement in stool quality, whereas, for 8 (~18%) participants the stool 
quality worsened. The percentage of ideal stools per week during the intervention, as compared to baseline 
period was significantly higher (61.4±28.6% vs 47.8±29.4%; P<0.01; Figure 5.3B). When comparing 
the percentage of constipation-associated stool types (type 1 and 2) during the baseline- and intervention 
period, 21 (~48%) participants experienced an improvement, 16 (~36%) participants experienced no 
difference and for 7 (~16%) participants the stool quality worsened. Overall, there was a significantly lower 
percentage of constipation stool types per week during intervention, compared to baseline (5.4±13.8% 
vs 13.2±23.5%; P< 0.01; Figure 5.3C). When comparing the percentage of diarrhoea-associated stool 
types (type 5, 6 and 7) during the baseline- and intervention period, 26 (~59%) participants experienced 
an improvement, 1 (~2%) participant experienced no difference and for 17 (~39%) participants the stool 
quality worsened. Overall, there was a significant lower percentage of diarrhoea stool types per week during 
intervention, compared to baseline (33.2±27.7% vs 39.0±31.6%; P<0.05; Figure 5.3D).
Consumption of the probiotic product did not lower the number of patients obeying Rome III criterion 
(≤2 defecations per week) during the intervention period compared to the baseline (P>0.05). The study 
product was well tolerated in all the participants. There occurred no adverse events (AEs) related to the 
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Figure 5.3. (A) Bowel movements, (B) ideal stool, (C) constipation and (D) diarrhoea. The displays show the improvements 
for each patient in percent points regarding the incidence of specified stool types per week (ideal/constipation/diarrhoea) 
between the intervention and baseline period respectively. Each figure is accompanied by its respective Q-Q-plot as a check 
for normality. C is not normally distributed.
5.5.  Discussion
The data of this pilot study indicate that LcS fermented milk can significantly improve bowel habits of frail 
elderly residents in a nursing home. The use of a probiotic drink containing LcS is already associated with 
boosting the immunity of elderly volunteers, for instance, by increasing the natural killer cell activity and 
displaying a more anti-inflammatory cytokine profile (Dong et al., 2013). This suggests that probiotics can 
induce in addition to a local gastrointestinal effect, a far more widespread beneficial systemic effect.
The percentage of diarrhoea-associated stools (type 5, 6 and 7) per week was significantly lower during 
the probiotic intervention as compared to the baseline period. This might suggest that administration of a 
probiotic fermented milk beverage can reduce the incidence of diarrhoea in elderly residents in a nursing 
home. Indeed in children ageing 1-5 y, administration of LcS had a protective effect of 14% (95% CI: 4-23, 
P<0.01) for diarrhoea (Sur et al., 2011). Whether the stool types 5, 6 and 7 in the elderly were caused by 
AAD remains to be determined; stool types were not stratified for antibiotics usage. Wright et al. (in press), 
were not able to demonstrate an effect of a LcS-containing beverage on AAD in geriatric patients. However, 
this study was underpowered to detect a significant effect and the administration period was relatively short 
(Wright et al., in press). LcS supplementation did show promising results in lowering the incidence of AAD 





The percentage of constipation-associated stools (type 1 and 2) per week was significantly lower during the 
probiotic intervention compared to the baseline period. However, there was no significant difference in 
percentage of participants with ≤2 defecations per week. Whether supplementation with LcS improves stool 
consistency and defecation frequency in constipated participants remains questionably, as literature does not 
provide convincing evidence (Koebnick et al., 2003; Mazlyn et al., 2013; Sakai et al., 2011). If this is due 
to a relatively short intervention period remains to be determined. It is not unlikely that improvements in 
defecation frequency will be observed only after long-term administration. The reduction of both diarrhoea 
and constipation associated stool types resulted in a significantly higher percentage of ideal stool type (type 
3 and 4) per week during the probiotic intervention compared to the baseline period.
Although the total number of bowel movements did not differ significantly compared to the baseline, 
other studies did show a moderate effect. In a randomised placebocontrolled trial, administration of LcS 
in healthy individuals with soft stools significantly improved the stool quality and decreased the defecation 
frequency (Matsumoto et al., 2010). In constipated female students, consumption of a synbiotic fermented 
milk beverage containing LcS resulted in a significant increase in bowel movements compared to the placebo 
group (Shioiri et al., 2006). Whereas these studies solely evaluated relatively healthy individuals with soft 
stool types and individuals with constipation, this current study demonstrated an improvement of all stool 
types (both diarrhoea and constipation) in relatively frail elderly individuals (as mentioned in the results).
The observed results in bowel habits were not related to a difference in laxative usage between the 
intervention- and baseline-period. The laxative intake was not significantly different during the intervention 
period compared to the baseline, demonstrating that the observed improvement in bowel habits can indeed 
be attributed to the introduction of the probiotic product and cannot be ascribed to changes in laxative 
usage. However, a further stratification of the data on laxative usage is, in this study, not possible due to 
limited number of patients that could be included for the statistical analysis. Preferably, a reduction in 
laxative usage is observed during the intervention period. However, there were no predetermined criteria 
for prescribing laxatives. Therefore it is possible that nursing staff were inclined to administer laxatives (e.g. 
plum compote), even if not necessary.
During this pilot study, no AEs were reported. This is in line with a previous study of van Puyenbroeck et al. 
(2012) were 737 individuals aged ≥65 y in nursing homes were randomly assigned to receive a LcS (n=375; 
1.3×1010 cfu LcS/day) or a placebo (n=362) for 21 days. During this study there were no AEs reported 
associated with consumption of L. casei Shirota, further advocating the safety of this strain in relative fragile 
individuals (Van Puyenbroek et al., 2012). In addition, no AEs were reported in very old individuals (mean 
age of 83 y) consuming a high dosage of 4.0×1010 cfu LcS/day (Nagata et al., 2011). Currently, there are no 
indications that probiotics are unsafe in a controlled setting, even in preterm infants and severely immune 
comprised adults (Van den Nieuwboer et al., 2014, 2015). Indeed, the FAO designated a GRAS (generally 
recognised as safe) status to LcS (GRN000429).
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In short, these data indicate that a LcS fermented milk beverage significantly improves stool quality of frail 
elderly residents of a nursing home by a reduction of diarrhoea and constipation stool types and an increase 
in ideal stool types. These promising results should be confirmed by a randomised, controlled, parallel study. 
Whereas other strains (e.g. LGG) already have a well-established evidencebase for diarrhoea (Floch et al., 
2011), data to support the use of LcS to improve bowel habits is still in development. If these data can be 
confirmed, there is a huge opportunity to significantly improve the QoL of elderly in nursing homes and 
reduce healthcare costs and workload.
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